ClinicalTrials.gg
RecruitingNCT07787871TEP-APUpdated Aug 26, 2026

Effect of Acupressure on Postoperative Pain After Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair

An interventional study of Acupressure and Sham Acupressure in Postoperative Pain and Inguinal Hernia, sponsored by Medipol University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Medipol University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This randomized, sham-controlled clinical trial aims to evaluate the effect of acupressure on postoperative pain following laparoscopic totally extraperitoneal (TEP) inguinal hernia repair.

A total of 90 participants will be randomly assigned to one of three groups: standard postoperative care alone (control group), true acupressure plus standard care, or sham acupressure plus standard care. Acupressure will be applied at postoperative hours 1, 4, and 8 using the bilateral P6 (Neiguan), LI4 (Hegu), ST36 (Zusanli), and SP6 (Sanyinjiao) acupoints. The sham group will receive pressure at non-acupuncture points.

The primary outcome is postoperative pain intensity measured using the Visual Analog Scale (VAS). Secondary outcomes include analgesic consumption, postoperative nausea and vomiting, time to mobilization, patient satisfaction, and postoperative complications.

Read the detailed description

Postoperative pain after laparoscopic totally extraperitoneal (TEP) inguinal hernia repair remains an important clinical problem despite advances in minimally invasive surgery. Acupressure is a non-invasive complementary therapy that may reduce postoperative pain and improve recovery.

This prospective, randomized, sham-controlled, three-arm clinical trial will enroll 90 adult patients undergoing elective laparoscopic TEP inguinal hernia repair.

Participants will be randomly allocated in a 1:1:1 ratio into:

  • Control group: Standard postoperative care only.
  • Acupressure group: Standard postoperative care plus bilateral acupressure applied at P6 (Neiguan), LI4 (Hegu), ST36 (Zusanli), and SP6 (Sanyinjiao).
  • Sham acupressure group: Standard postoperative care plus pressure applied to non-acupuncture points.

Each intervention will be administered at postoperative hours 1, 4, and 8. Pressure will be applied manually for approximately 3 minutes at each point bilaterally by trained personnel.

Pain intensity will be evaluated using the Visual Analog Scale (VAS) at predetermined postoperative time points. Secondary outcomes include total analgesic consumption, incidence of postoperative nausea and vomiting, time to mobilization, patient satisfaction, and postoperative complications.

The study is designed to determine whether true acupressure provides additional benefit beyond standard care and whether its effects differ from sham acupressure, thereby distinguishing specific therapeutic effects from placebo responses.

02

Conditions studied

  • Postoperative Pain
  • Inguinal Hernia

Keywords

  • Acupressure
  • Sham Acupressure
  • TEP
  • Laparoscopic Totally Extraperitoneal Hernia Repair
  • Inguinal Hernia
  • Postoperative Pain
  • Randomized Controlled Trial
  • Visual Analog Scale
  • Complementary Medicine
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 90 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Medipol University is the lead sponsor of 326 studies on the registry; 88 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 75 years
  • Diagnosis of a unilateral primary inguinal hernia
  • Scheduled to undergo elective laparoscopic total extraperitoneal (TEP) inguinal hernia repair
  • (ASA) physical status I to III without an anticipated need for postoperative intensive care
  • Ability to understand the study procedures and provide written

Exclusion criteria

Exclusion Criteria:

Bilateral inguinal hernia

  • Recurrent inguinal hernia
  • Strangulated inguinal hernia
  • History of open lower abdominal surgery
  • Skin infection, wound, or surgical scar at any of the acupressure application sites
  • III with an anticipated need for postoperative intensive care
  • ASA physical status IV
  • Participation in another clinical study within the previous 4 weeks
  • Receipt of acupressure or a similar complementary treatment within the previous 4 weeks
  • Refusal or inability to provide written
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • No intervention
    Control

    Participants receive standard postoperative care without acupressure.

  • Experimental
    Acupressure

    Participants receive standard postoperative care plus true acupressure at bilateral P6, LI4, ST36, and SP6 points for 3 minutes per point at postoperative 1, 4, and 8 hours.

    Procedure: Acupressure

  • Sham comparator
    Sham Acupressure

    Participants receive standard postoperative care plus sham acupressure at non-acupoint locations with the same duration and schedule as the acupressure group.

    Procedure: Sham Acupressure

Interventions

  • ProcedureAcupressure

    Bilateral acupressure is applied at P6, LI4, ST36, and SP6 for 3 minutes per point at postoperative 1, 4, and 8 hours.

  • ProcedureSham Acupressure

    Manual pressure is applied to non-acupuncture points using the same duration and schedule as the active acupressure intervention.

06

What researchers measure

Primary outcomes

  1. Postoperative Pain Intensity Assessed by Visual Analog Scale

    Postoperative pain intensity will be assessed using a Visual Analog Scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. VAS scores will be recorded at postoperative hours 2, 4, 6, 12, and 24 and compared among the study groups.

    Time frame: At postoperative hours 2, 4, 6, 12, and 24

Secondary outcomes

  1. Rescue Analgesic Requirement

    The requirement for rescue analgesic medication and the number of analgesic administrations will be recorded from the patient medication chart and compared among the study groups.

    Time frame: During the first 24 postoperative hours

  2. Incidence of Postoperative Nausea and Vomiting

    The presence of postoperative nausea and the number of vomiting episodes will be recorded and compared among the study groups.

    Time frame: During the first 24 postoperative hours

  3. Early Postoperative Complications

    The occurrence and type of early postoperative complications will be recorded and compared among the study groups.

    Time frame: During the first 24 postoperative hours

  4. Rescue Antiemetic Requirement

    The requirement for rescue antiemetic medication and the number of antiemetic administrations will be recorded from the patient medication chart and compared among the study groups.

    Time frame: During the first 24 postoperative hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data will not be made publicly available due to participant confidentiality and institutional data protection requirements. Aggregate study results will be reported in scientific publications.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07787871
Lead sponsor
Medipol University
Responsible party
ahmet said yaz (Principal investigator, Medipol University) — Principal investigator
First posted
Aug 26, 2026
Start date
Jun 20, 2026
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Aug 26, 2026

Study contacts

AHMET S YAZ, MD
Contact
ahmet.yaz@std.medipol.edu.tr
+902165783000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion